Latest Johns Hopkins Stories
BALTIMORE, FRI., APRIL 17, 10AM, INSTITUTES FOR BEHAVIOR RESOURCES, 2104 MARYLAND AVE. Demonstration During Event; Major New Tool to Reach Additional Victims BALTIMORE, April 13 /PRNewswire-USNewswire/ -- Four-Star General Barry McCaffrey, the former White House Drug Czar, Rep. Elijah Cummings (D-Balt), Chair of the Congressional Drug Policy Caucus, and Dr. Barry Karlin, CEO of CRC Health Group, the nation's largest substance abuse treatment provider, join Johns...
A study by researchers at Johns Hopkins University found an association between increasing levels of indoor particulate matter pollution and the severity of asthma symptoms among children. The study, which followed a group of asthmatic children in Baltimore, Md., is among the first to examine the effects of indoor particulate matter pollution. The results are published in the February 2009 edition of the journal Environmental Health Perspectives.Particulate matter is an airborne mixture of...
Awareness and sensitivity to racial and ethnic diversity are believed by most U.S. medical school faculty to be poor, researchers said. A survey, conducted at the Johns Hopkins University School of Medicine, is likely a reflection of diversity issues thought to persist at academic medical institutions across the country, said principal investigator Dr. Lisa Cooper, of the Johns Hopkins Bloomberg School of Public Health. What we are seeing at Johns Hopkins is likely to be the case in medical...
Johns Hopkins and other researchers report what is believed to be the first direct evidence in lab animals that the erectile dysfunction drug sildenafil amplifies the effects of a heart-protective protein.The team's findings, to be published in the Journal of Clinical Investigation online Jan. 5, helps explain why sildenafil, more widely known as Viagra, has already been shown to improve heart function and may one day have value in either treating or preventing heart damage due to chronic...
Johns Hopkins scientists identify receptor type that makes cancer cells resistant to therapy, more aggressiveThe hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. The findings, reported in the Jan. 1 issue...
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the National Fibromyalgia Association announced today the launch of the Fibromyalgia Circle of Care Initiative at the ACR/ARHP Annual Scientific Meeting, October 24-29, 2008 in San Francisco. The outcomes-based educational initiative will educate providers about the disease state and the latest therapeutic options; thus, driving accurate and early diagnosis of fibromyalgia for the ten million U.S....
Johns Hopkins - rated by U.S. News & World Report as the nation's number one hospital for the 18th consecutive year - executed a comprehensive agreement with iMDsoft to implement MetaVision Anesthesia Information Management System (AIMS) across its entire perioperative continuum. The hospital will initially deploy iMDsoft's MetaVision AIMS in two hundred and fifty ORs, PACU beds, and preop locations in its main campus. Subsequent rollout at Johns Hopkins Bayview facility is planned for...
The Johns Hopkins School of Medicine, The Institute for Johns Hopkins Nursing, The University of Kentucky Colleges of Pharmacy and Medicine, and The Integrative Neurobiology Educational Alliance (INEA) today announced the launch of an ambitious continuing medical education (CME) initiative designed to educate a variety of healthcare providers on the neurobiology of insomnia. The Neurobiology of Insomnia Educational Initiative (NOI) is a multidisciplinary, performance improvement activity...
BOCA RATON, Fla., Sept. 23 /PRNewswire/ -- It's scary enough that the average doctor's visit lasts less than 20 minutes, worse still that the time wasted in waiting rooms can easily exceed three times that! It can be next to impossible to cover every pressing medical concern when everyone is so pressed for time. In the long-run, this "wham bam, thank you ma'am" approach can leave patients clinging to the proverbial short end of the stick. According to one physician, Traci...
WINNIPEG, Sept. 11 /PRNewswire-FirstCall/ -- IMRIS (TSX: IM) announced today the sale of their flagship product, IMRISneuro, to one of the world's leading neuroscience centers, The Johns Hopkins Hospital in Baltimore, Maryland. IMRISneuro is a fully integrated operating room including the IMRIS one-of-a kind, movable high field MRI. The new technology allows surgeons to safely image patients in the operating room during brain surgery, helping to rule out complications before the patient...
